| Product Code: ETC9959704 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Atherosclerosis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Atherosclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Atherosclerosis Market - Industry Life Cycle |
3.4 United States (US) Atherosclerosis Market - Porter's Five Forces |
3.5 United States (US) Atherosclerosis Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.6 United States (US) Atherosclerosis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 United States (US) Atherosclerosis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United States (US) Atherosclerosis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United States (US) Atherosclerosis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United States (US) Atherosclerosis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Atherosclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of lifestyle-related diseases such as obesity and diabetes, contributing to the rise in atherosclerosis cases. |
4.2.2 Technological advancements in diagnostic tools and treatment options leading to better disease management. |
4.2.3 Growing awareness about preventive measures and early detection of atherosclerosis among the population. |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing atherosclerosis, limiting access to care for some patients. |
4.3.2 Stringent regulatory requirements for drug approvals and medical devices can delay the introduction of new treatments. |
4.3.3 Rising concerns regarding the side effects and long-term implications of current atherosclerosis medications. |
5 United States (US) Atherosclerosis Market Trends |
6 United States (US) Atherosclerosis Market, By Types |
6.1 United States (US) Atherosclerosis Market, By Stages |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Atherosclerosis Market Revenues & Volume, By Stages, 2021- 2031F |
6.1.3 United States (US) Atherosclerosis Market Revenues & Volume, By Endothelial Damage and Immune Response, 2021- 2031F |
6.1.4 United States (US) Atherosclerosis Market Revenues & Volume, By Fatty Streak, 2021- 2031F |
6.1.5 United States (US) Atherosclerosis Market Revenues & Volume, By Plaque Growth, 2021- 2031F |
6.1.6 United States (US) Atherosclerosis Market Revenues & Volume, By Plaque Rupture, 2021- 2031F |
6.2 United States (US) Atherosclerosis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Atherosclerosis Market Revenues & Volume, By Ankle-brachial Index (ABI), 2021- 2031F |
6.2.3 United States (US) Atherosclerosis Market Revenues & Volume, By Doppler Ultrasound, 2021- 2031F |
6.2.4 United States (US) Atherosclerosis Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.2.5 United States (US) Atherosclerosis Market Revenues & Volume, By Electrocardiogram (ECG), 2021- 2031F |
6.2.6 United States (US) Atherosclerosis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.7 United States (US) Atherosclerosis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Atherosclerosis Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Atherosclerosis Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 United States (US) Atherosclerosis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.4 United States (US) Atherosclerosis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Atherosclerosis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Atherosclerosis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United States (US) Atherosclerosis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 United States (US) Atherosclerosis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Atherosclerosis Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Atherosclerosis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United States (US) Atherosclerosis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United States (US) Atherosclerosis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 United States (US) Atherosclerosis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United States (US) Atherosclerosis Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Atherosclerosis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United States (US) Atherosclerosis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United States (US) Atherosclerosis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 United States (US) Atherosclerosis Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Atherosclerosis Market Import-Export Trade Statistics |
7.1 United States (US) Atherosclerosis Market Export to Major Countries |
7.2 United States (US) Atherosclerosis Market Imports from Major Countries |
8 United States (US) Atherosclerosis Market Key Performance Indicators |
8.1 Average age of diagnosis for atherosclerosis patients. |
8.2 Percentage of atherosclerosis patients undergoing regular screenings for early detection. |
8.3 Number of research studies and clinical trials focused on developing new treatments for atherosclerosis. |
9 United States (US) Atherosclerosis Market - Opportunity Assessment |
9.1 United States (US) Atherosclerosis Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.2 United States (US) Atherosclerosis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 United States (US) Atherosclerosis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United States (US) Atherosclerosis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United States (US) Atherosclerosis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United States (US) Atherosclerosis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Atherosclerosis Market - Competitive Landscape |
10.1 United States (US) Atherosclerosis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Atherosclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here